Germline O
mutations O
in O
BRCA1 O
are O
responsible O
for O
most O
cases O
of O
inherited B
breast I
and I
ovarian I
cancer I
. O

To O
investigate O
whether O
the O
presence O
of O
rare O
HRAS1 O
alleles O
increases O
susceptibility O
to O
hereditary B
breast I
and I
ovarian I
cancer I
, O
we O
have O
typed O
a O
panel O
of O
307 O
female O
BRCA1 O
carriers O
at O
this O
locus O
using O
a O
PCR O
- O
based O
technique O
. O

A O
novel O
homeodomain O
- O
encoding O
gene O
is O
associated O
with O
a O
large O
CpG O
island O
interrupted O
by O
the O
myotonic B
dystrophy I
unstable O
( O
CTG O
) O
n O
repeat O
. O

We O
have O
analyzed O
the O
27 O
exons O
and O
the O
promoter O
region O
of O
the O
RB1 O
gene O
in O
familial B
or I
sporadic I
bilateral I
retinoblastoma I
by O
using O
single O
- O
strand O
conformation O
polymorphism O
analysis O
. O

Defective O
dimerization O
of O
von B
Willebrand I
factor O
subunits O
due O
to O
a O
Cys O
- O
> O
Arg O
mutation O
in O
type B
IID I
von I
Willebrand I
disease I
. O

The O
same O
heterozygous O
T O
- O
> O
C O
transition O
at O
nt O
8567 O
of O
the O
von B
Willebrand I
factor O
( O
vWF O
) O
transcript O
was O
found O
in O
two O
unrelated O
patients O
with O
type B
IID I
von I
Willebrand I
disease I
, O
with O
no O
other O
apparent O
abnormality O
. O

We O
conclude O
that O
CyS2010 O
is O
essential O
for O
normal O
dimerization O
of O
vWF O
subunits O
through O
disulfide O
bonding O
of O
carboxyl O
- O
terminal O
domains O
and O
that O
a O
heterozygous O
mutation O
in O
the O
corresponding O
codon O
is O
responsible O
for O
defective O
multimer O
formation O
in O
type B
IID I
von I
Willebrand I
disease I
. O
. O

An O
exception O
is O
BRCA1 O
, O
which O
contributes O
to O
a O
significant O
fraction O
of O
familial B
breast I
and I
ovarian I
cancer I
, O
but O
undergoes O
mutation O
at O
very O
low O
rates O
in O
sporadic B
breast I
and I
ovarian I
cancers I
. O

An O
exception O
is O
BRCA1 O
, O
which O
contributes O
to O
a O
significant O
fraction O
of O
familial B
breast I
and I
ovarian I
cancer I
, O
but O
undergoes O
mutation O
at O
very O
low O
rates O
in O
sporadic B
breast I
and I
ovarian I
cancers I
. O

Founding O
BRCA1 O
mutations O
in O
hereditary B
breast I
and I
ovarian I
cancer I
in O
southern O
Sweden O
. O

Strikingly O
, O
mice O
carrying O
multiple O
copies O
on O
a O
wild O
- O
type O
background O
show O
specific O
developmental B
abnormalities I
of I
the I
eye I
, O
but O
not O
of O
other O
tissues O
expressing O
the O
gene O
. O

We O
describe O
the O
proportion O
of O
hereditary B
breast I
cancer I
explained O
by O
BRCA1 O
or O
BRCA2 O
in O
a O
sample O
of O
North O
American O
hereditary B
breast I
cancers I
and O
assess O
the O
evidence O
for O
additional O
susceptibility O
genes O
that O
may O
confer O
hereditary B
breast I
or I
ovarian I
cancer I
risk O
. O

To O
define O
the O
possible O
role O
of O
the O
VHL B
gene O
in O
the O
development O
of O
sporadic B
renal I
cell I
carcinomas I
, O
91 O
different O
parenchymal B
tumours I
of I
the I
kidney I
have O
been O
investigated O
for O
mutation O
of O
the O
VHL B
gene O
by O
single O
strand O
conformation O
polymorphism O
( O
SSCP O
) O
and O
/ O
or O
heteroduplex O
( O
HD O
) O
techniques O
. O

The O
Emery B
- I
Dreifuss I
muscular I
dystrophy I
protein O
, O
emerin O
, O
is O
a O
nuclear O
membrane O
protein O
. O

A O
muscle O
biopsy O
from O
an O
Emery B
- I
Dreifuss I
muscular I
dystrophy I
( O
EMDM B
) O
patient O
showed O
complete O
absence O
of O
emerin O
by O
both O
Western O
blotting O
and O
immunohistochemistry O
, O
suggesting O
a O
simple O
diagnostic O
antibody O
test O
for O
EDMD B
families O
. O

Classical O
phenylketonuria B
( O
PKU B
) O
is O
an O
autosomal B
recessive I
disorder I
caused O
by O
a O
deficiency B
of I
hepatic I
phenylalanine I
hydroxylase I
( O
PAH O
) O
. O

Mutations O
in O
BRCA1 O
account O
for O
approximately O
45 O
% O
of O
familial B
breast I
cancer I
and O
90 O
% O
of O
inherited B
breast I
/ I
ovarian I
cancer I
, O
whereas O
mutations O
in O
BRCA2 O
account O
for O
a O
comparable O
percentage O
of O
inherited B
breast I
cancer I
cases O
. O

HPRT B
- I
APRT I
- I
deficient I
mice O
are O
not O
a O
model O
for O
lesch B
- I
nyhan I
syndrome I
. O

To O
test O
this O
proposition O
, O
we O
bred O
HPRT B
- I
APRT I
- I
deficient I
mice O
. O

Thus O
, O
APRT B
- I
HPRT I
- I
deficient I
mice O
, O
which O
are O
devoid O
of O
any O
purine O
salvage O
pathways O
, O
show O
no O
novel O
phenotype O
and O
are O
not O
a O
model O
for O
the O
behavioral B
abnormalities I
associated O
with O
the O
Lesch B
- I
Nyhan I
syndrome I
as O
previously O
suggested O

Association O
studies O
in O
two O
independent O
samples O
totaling O
505 O
individuals O
revealed O
that O
the O
5 O
- O
HTT O
polymorphism O
accounts O
for O
3 O
to O
4 O
percent O
of O
total O
variation O
and O
7 O
to O
9 O
percent O
of O
inherited O
variance O
in O
anxiety B
- I
related I
personality I
traits I
in O
individuals O
as O
well O
as O
sibships O
. O
. O

The O
Wiskott B
- I
Aldrich I
syndrome I
( O
WAS B
) O
, O
an O
X B
- I
linked I
immunodeficiency I
disease I
caused O
by O
mutation O
in O
the O
recently O
isolated O
gene O
encoding O
WAS B
protein O
( O
WASP O
) O
, O
is O
known O
to O
be O
associated O
with O
extensive O
clinical O
heterogeneity O
. O

The O
hereditary B
breast I
and I
ovarian I
cancer I
gene O
, O
BRCA1 O
, O
encodes O
a O
large O
polypeptide O
that O
contains O
the O
cysteine O
- O
rich O
RING O
motif O
, O
a O
zinc O
- O
binding O
domain O
found O
in O
a O
variety O
of O
regulatory O
proteins O
. O

45 O
- O
kilobases O
( O
kb O
) O
exon O
11 O
of O
the O
hereditary B
breast I
and I
ovarian I
cancer I
gene O
BRCA1 O
. O

Autosomal O
dominant O
primary O
hyperparathyroidism B
and I
jaw I
tumor I
syndrome I
associated O
with O
renal B
hamartomas I
and O
cystic B
kidney I
disease I
: O
linkage O
to O
1q21 O
- O
q32 O
and O
loss O
of O
the O
wild O
type O
allele O
in O
renal B
hamartomas I
. O

We O
report O
a O
novel O
missense O
change O
in O
BRCA1 O
, O
2640 O
C O
- O
- O
> O
T O
( O
R841W O
) O
, O
found O
in O
3 O
cases O
from O
a O
subject O
group O
of O
305 O
breast B
and I
79 I
ovarian I
cancer I
cases O
from O
Orange O
County O
, O
CA O
. O

A O
population O
- O
based O
series O
of O
54 O
male B
breast I
cancer I
cases O
from O
Southern O
California O
were O
analyzed O
for O
germ O
- O
line O
mutations O
in O
the O
inherited B
breast I
/ I
ovarian I
cancer I
genes O
, O
BRCA1 O
and O
BRCA2 O
. O

Human O
orythrocytes O
that O
are O
homozygous O
for O
the O
Duarte B
enzyme I
variant I
of I
galactosemia I
( O
D O
/ O
D O
) O
have O
a O
characteristic O
isoform O
on O
isoelectric O
focusing O
and O
50 O
% O
reduction O
in O
galactose O
- O
1 O
- O
phosphate O
uridyltransferase O
( O
GALT O
) O
enzyme O
activity O
. O

The O
clinical O
picture O
resembles O
somewhat O
that O
of O
X B
- I
linked I
spastic I
paraplegia I
( O
SPG B
) O
. O

Heterogeneity O
in O
Schwartz B
- I
Jampel I
chondrodystrophic I
myotonia I
. O

WT1 O
mutations O
have O
also O
been O
reported O
in O
juvenile B
granulosa I
cell I
tumour I
, O
non B
- I
asbestos I
related I
mesothelioma I
, O
desmoplastic B
small I
round I
cell I
tumour I
and O
, O
most O
recently O
, O
acute B
myeloid I
leukemia I
. O
. O

WT1 O
mutations O
have O
also O
been O
reported O
in O
juvenile B
granulosa I
cell I
tumour I
, O
non B
- I
asbestos I
related I
mesothelioma I
, O
desmoplastic B
small I
round I
cell I
tumour I
and O
, O
most O
recently O
, O
acute B
myeloid I
leukemia I
. O
. O

Autosomal B
dominant I
myotonia I
congenita I
is O
an O
inherited B
disorder I
of I
skeletal I
muscle I
caused O
by O
mutations O
in O
a O
voltage O
- O
gated O
Cl O
- O
channel O
gene O
( O
CLCN1 O
, O
7q35 O
) O
. O

Insulin O
gene O
region O
contributes O
to O
genetic O
susceptibility O
to O
, O
but O
may O
not O
to O
low O
incidence O
of O
, O
insulin B
- I
dependent I
diabetes I
mellitus I
in O
Japanese O
. O

In O
the O
Caucasian O
population O
, O
it O
has O
been O
demonstrated O
that O
the O
insulin O
gene O
( O
INS O
) O
region O
contains O
the O
insulin B
- I
dependent I
diabetes I
mellitus I
locus O
( O
IDDM2 O
) O
. O

Deficiency B
of I
terminal I
complement I
components I
is O
generally O
associated O
with O
recurrent O
neisseria B
infections I
. O

The O
von B
Hippel I
- I
Lindau I
tumor I
suppressor O
gene O
product O
interacts O
with O
Sp1 O
to O
repress O
vascular O
endothelial O
growth O
factor O
promoter O
activity O
. O

The O
von B
Hippel I
- I
Lindau I
tumor I
suppressor O
gene O
( O
VHL O
) O
has O
a O
critical O
role O
in O
the O
pathogenesis O
of O
clear B
- I
cell I
renal I
cell I
carcinoma I
( O
RCC B
) O
, O
as O
VHL O
mutations O
have O
been O
found O
in O
both O
von B
Hippel I
- I
Lindau I
disease I
- I
associated I
and I
sporadic I
RCCs I
. O

These O
observations O
support O
a O
new O
mechanism O
for O
VHL O
- O
mediated O
transcriptional O
repression O
via O
a O
direct O
inhibitory O
action O
on O
Sp1 O
and O
suggest O
that O
loss O
of O
Sp1 O
inhibition O
may O
be O
important O
in O
the O
pathogenesis O
of O
von B
Hippel I
- I
Lindau I
disease I
and O
RCC B
. O
. O

Adult B
onset I
globoid I
cell I
leukodystrophy I
( O
Krabbe B
disease I
) O
: O
analysis O
of O
galactosylceramidase O
cDNA O
from O
four O
Japanese O
patients O
. O

We O
examined O
galactosylceramidase O
( O
GALC O
) O
cDNA O
in O
four O
Japanese O
patients O
with O
adult B
onset I
globoid I
cell I
leukodystrophy I
( O
Krabbe B
disease I
; O
AO B
- I
GLD I
) O
by O
polymerase O
chain O
reaction O
/ O
single O
- O
strand O
conformation O
polymorphism O
( O
PCR O
- O
SSCP O
) O
analysis O
, O
subsequent O
sequence O
determination O
, O
and O
restriction O
enzyme O
digestion O
of O
PCR O
products O
, O
initial O
symptoms O
were O
the O
onset O
of O
slowly O
progressive O
spastic B
paraplegia I
from O
the O
middle O
of O
the O
second O
decade O
, O
and O
all O
patients O
had O
diminished B
GALC I
activity I
in O
their O
leukocytes O
. O

